Chemed(DE:CXM)
€498.00+2.00 (+0.40%)
DE:CXM
Chemed earnings date
€498.00
At close:+2.00 (+0.40%)
Chemed (CXM) Q2 2023 Earnings Report
2 Followers
DE:CXM Q2 2023 EPS Results
- Actual EPS
- EUR 4.29
- Consensus EPS
- EUR 4.64
- Beat/Miss
- Missed by -EUR 0.34
- One Year Ago EPS
- EUR 4.41
DE:CXM Q2 2023 Revenue Results
- Actual Revenue
- EUR 504.85M
- Expected Revenue
- EUR 512.80M
- Beat/Miss
- Missed by -EUR 7.95M
- YoY Revenue Growth
- +4.24%
Earnings Announcement Details
- Quarter
- Q2 2023
- Date
- 07/26/2023
- Time
- After Close
- Conference Call
- Wednesday, July 26, 2023
DE:CXM Upcoming Earnings
Chemed's next earnings date is estimated for February 25, 2027, based on past reporting schedules.
Q2 2023 Earnings Call Audio
DE:CXM Q2 2023 Earnings Call
0:00 / 0:00
Q2 2023 Earnings Slide Deck
Q2 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:CXM Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 25, 2027 | 2026 (Q4) | 6.70- | 5.85 | ― | ― |
| Oct 27, 2026 | 2026 (Q3) | 5.876.15 | 4.8 | 28.08% (+1.35) | |
| Jul 28, 2026 | 2026 (Q2) | 5.105.52 | 3.89 | 41.92% (+1.63) | |
| Apr 23, 2026 | 2026 (Q1) | 4.835.15 | 5.13 | 0.36% (+0.02) | |
| Feb 25, 2026 | 2025 (Q4) | 6.415.85 | 6.23 | -6.00% (-0.37) | |
| Oct 31, 2025 | 2025 (Q3) | 4.894.80 | 5.14 | -6.56% (-0.34) | |
| Jun 30, 2025 | 2025 (Q2) | 4.673.89 | 4.99 | -21.94% (-1.09) | |
| Apr 23, 2025 | 2025 (Q1) | 5.065.13 | 4.74 | 8.27% (+0.39) | |
| Feb 26, 2025 | 2024 (Q4) | 6.186.23 | 6.02 | 3.48% (+0.21) | |
| Oct 29, 2024 | 2024 (Q3) | 5.155.14 | 4.85 | 6.02% (+0.29) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed


